Sporotrichosis natural history, complications and prognosis: Difference between revisions
Jump to navigation
Jump to search
| Line 12: | Line 12: | ||
==Prognosis== | ==Prognosis== | ||
*''S. schencki''i is an apparent opportunistic pathogen, as severe clinical forms of this disease have been linked with immunodeficient patients. | |||
*Resistance to ''S. schenckii'' is not linked to the host’s inherent ability to fight the fungal infection, but rather results from the level of immunity that the host acquires during the initial stage, which is characterized by a large pathogen presence within the organs.<ref name="pmid15681154">{{cite journal| author=Nascimento RC, Almeida SR| title=Humoral immune response against soluble and fractionate antigens in experimental sporotrichosis. | journal=FEMS Immunol Med Microbiol | year= 2005 | volume= 43 | issue= 2 | pages= 241-7 | pmid=15681154 | doi=10.1016/j.femsim.2004.08.004 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15681154 }} </ref> | |||
*Resultantly, depending on the host's immune system capacity at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as good. | |||
==References== | ==References== | ||
Revision as of 14:49, 11 January 2016
|
Sporotrichosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Sporotrichosis natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Sporotrichosis natural history, complications and prognosis |
|
FDA on Sporotrichosis natural history, complications and prognosis |
|
CDC on Sporotrichosis natural history, complications and prognosis |
|
Sporotrichosis natural history, complications and prognosis in the news |
|
Blogs on Sporotrichosis natural history, complications and prognosis |
|
Risk calculators and risk factors for Sporotrichosis natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Alison Leibowitz [2]
Overview
Natural History
Complications
- Cutaneous lesions can become superinfected with bacteria, resulting in cellulitis.
- 5-fluorocytosine therapy may result in photosensitivity[1]
Prognosis
- S. schenckii is an apparent opportunistic pathogen, as severe clinical forms of this disease have been linked with immunodeficient patients.
- Resistance to S. schenckii is not linked to the host’s inherent ability to fight the fungal infection, but rather results from the level of immunity that the host acquires during the initial stage, which is characterized by a large pathogen presence within the organs.[2]
- Resultantly, depending on the host's immune system capacity at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as good.
References
- ↑ Shelley WB, Sica PA (1983). "Disseminate sporotrichosis of skin and bone cured with 5-fluorocytosine: Photosensitivity as a complication". J Am Acad Dermatol. 8 (2): 229–35. PMID 6826816.
- ↑ Nascimento RC, Almeida SR (2005). "Humoral immune response against soluble and fractionate antigens in experimental sporotrichosis". FEMS Immunol Med Microbiol. 43 (2): 241–7. doi:10.1016/j.femsim.2004.08.004. PMID 15681154.